Copy Link Print Information

9-ING-41

(Synonyms: Elraglusib)
6 Cited Publications
Revisión del cliente

Based on 6 publication(s) in Google Scholar

9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.13%
  • No. CAS: 1034895-42-5
  • Fòrmula: C22H13FN2O5
  • Peso molecular:404.35
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • 9-ING-41 Chemical Structure
    9-ING-41 Chemical Structure
  • Experimental Validation Results for 9-ING-41
  • Experimental Validation Results for 9-ING-41
  • Experimental Validation Results for 9-ING-41
  • Experimental Validation Results for 9-ING-41
  • Experimental Validation Results for 9-ING-41
No. CAS: 1034895-42-5
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) 9-ING-41

More
Customer Validation & Images
Cell Proliferation/Viability AssayCell Imaging/StainingHistological Imaging/StainingIHC
  • Cell Proliferation/Viability Assay
  • Cell Imaging/Staining
  • Cell Proliferation/Viability Assay
  • Histological Imaging/Staining
  • IHC

Ver todos los productos específicos de isoformas GSK-3

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 9-ING-41 Chemical Structure
    9-ING-41 Chemical Structure
    1/16
  • 1/16

    9-ING-41 purchased from MedChemExpress. Usage Cited in: Nature. 2025 Jun;642(8067):508-518. [Abstract]

    Customer Validation
     Analysis of cell viability in THP-1 cells treated with the indicated inhibitors for 5 days by the Cell-Titer-Glo assay.

  • 1/16

    9-ING-41 purchased from MedChemExpress. Usage Cited in: Nature. 2025 Jun;642(8067):508-518. [Abstract]

    Customer Validation
     Wright-Giemsa-stained cytospins for a DNMT3A-mutant primary AML sample treated with DMSO, IMG-7289 (50 nM), 9-ING-41 (100 nM) and combination of both inhibitors.

  • 1/16

    9-ING-41 purchased from MedChemExpress. Usage Cited in: Front Immunol. 2024 May 15:15:1360436. [Abstract]

    Customer Validation
     Bladder cancer cells (MB49) and normal cells (NIH3T3) were treated with 0–10 μM of 9-ING-41 for 48 h The cell viability was determined by MTT assay.

  • 1/16

    9-ING-41 purchased from MedChemExpress. Usage Cited in: Front Immunol. 2024 May 15:15:1360436. [Abstract]

    Customer Validation
     MB49 tumor tissues of mice treated with PBS, 9-ING-41 (10 mg/kg), HY-oAd, and HY-oAd+9-ING-41 were stained with Masson’s trichrome to assess collagen accumulation in the tumor tissues.

  • 1/16

    9-ING-41 purchased from MedChemExpress. Usage Cited in: Front Immunol. 2024 May 15:15:1360436. [Abstract]

    Customer Validation
     Immunohistochemical staining of CD4+ and CD8+ T cells from subcutaneous MB49 tumor tissue sections obtained after treatment with PBS, 9-ING-41 (10 mg/kg), HY-oAd, and HY-oAd+9-ING-41.

  • 9-ING-41